Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Isis Pharmaceuticals
Isis Pharmaceuticals
Is RNA Drug Development Coming of Age?
Motley Fool
Sat, 04/13/13 - 11:28 am
Sarepta Therapeutics
Isis Pharmaceuticals
Alnylam
Isis: Big Pharma's Little Friend
Motley Fool
Tue, 04/9/13 - 09:47 am
Isis Pharmaceuticals
Roche
Kynamro
Huntington's disease
Roche to use Isis's technology to develop brain disorder drug
Reuters
Mon, 04/8/13 - 12:54 pm
Roche
Isis Pharmaceuticals
Huntington's disease
antisense
Isis Publishes Encouraging Data
Yahoo/Zacks
Wed, 04/3/13 - 08:38 am
Isis Pharmaceuticals
antisense
Isis Ready To Break Out Ahead Of Conference, Myriad Catalysts This Year
Seeking Alpha
Tue, 03/5/13 - 11:27 am
Isis Pharmaceuticals
Glaxo Shells Out $7.5 Million for Milestone Payment to Isis
Yahoo/Zacks
Wed, 02/27/13 - 11:33 am
GSK
Isis Pharmaceuticals
ISIS-TTRRx
transthyretin amyloidosis
Isis Pharmaceuticals Launches Trial, Hits Milestone
Motley Fool
Fri, 02/22/13 - 10:39 am
Isis Pharmaceuticals
ISIS-TTR
antisense
GSK
transthyretin amyloidosis
TTR-mediated amyloidosis
Will Isis Right Pfizer's Wrong?
Motley Fool
Wed, 02/20/13 - 11:33 am
Pfizer
Isis Pharmaceuticals
Kynamro
generics
Isis: FDA Approval Of Kynamro Promises A Bright Future For Company
Seeking Alpha
Fri, 02/1/13 - 11:40 am
FDA
Kynamro
Isis Pharmaceuticals
Sanofi
Genzyme
Homozygous Familial Hypercholesterolemia
Isis Jumps as FDA Clears Cholesterol Treatment
Bloomberg
Wed, 01/30/13 - 05:59 pm
Isis Pharmaceuticals
FDA
cholesterol
treatment
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia
Forbes
Wed, 01/30/13 - 10:38 am
mipomersen
Kynamro
Isis Pharmaceuticals
Homozygous Familial Hypercholesterolemia
Genzyme
FDA
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 01/28/13 - 12:25 pm
Sanofi
Kynamro
Isis Pharmaceuticals
Regeneron
Eli Lilly
Pfizer
Merck
Alnylam: Rally On No News Leaves Room For Downside
Seeking Alpha
Thu, 01/24/13 - 10:35 am
Alnylam
Isis Pharmaceuticals
Better Cancer Treatment: Partnerships and Dividends
The Motley Fool
Sat, 01/19/13 - 12:12 pm
cancer
treatment
Isis Pharmaceuticals
Aegerion
Astra Zeneca
Faruqi & Faruqi, LLP Encourages Investors Who Suffered $100,000 In Losses Investing In Isis Pharmaceuticals, Inc. To Contact The Firm
Yahoo/PRNewswire
Sat, 01/19/13 - 12:09 pm
investment
Isis Pharmaceuticals
legal
Isis Wins at Wooing Wall Street
Motley Fool
Sat, 01/12/13 - 10:50 am
Isis Pharmaceuticals
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 01/12/13 - 10:47 am
Isis Pharmaceuticals
Celgene
Dynavax Technologies
Which Companies Are In Michael King's Oncology Wheelhouse?
Seeking Alpha
Sat, 01/12/13 - 10:44 am
Alnylam
Regulus
Isis Pharmaceuticals
SynaGeva BioPharma
Sarepta Therapeutics
Onyx
Celgene
Millennium
Takeda
Ariad Pharmaceuticals
Pharmacyclics
Astex
Gainey & McKenna Announces a Securities Fraud Class Action Lawsuit Has Been Filed Against ISIS Pharmaceuticals, Inc. -- ISIS
Yahoo/GlobeNewswire
Sat, 01/5/13 - 11:01 am
Isis Pharmaceuticals
lawsuit
legal
securities fraud
Better Than Lipitor! Higher Sales?
Motley Fool
Tue, 01/1/13 - 11:53 am
Pfizer
Lipitor
Juxtapid
Aegerion
Kynamro
Sanofi
Isis Pharmaceuticals
Regeneron
Alnylam
PCSK9 inhibitors
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »